title: Optimal hyaluronidase dosage: response.
authors.affiliation: Department of Ophthalmology, The Queen Elizabeth Hopsital, Adelaide, South Australia, Australia.
authors.forename: Katherine
authors.initials: K
authors.lastname: Zamora-Alejo
authors.forename: Sacha
authors.initials: S
authors.lastname: Moore
authors.forename: Brian
authors.initials: B
authors.lastname: Leatherbarrow
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Norris
authors.forename: Damien B
authors.initials: DB
authors.lastname: Lake
authors.forename: Raman
authors.initials: R
authors.lastname: Malhotra
authors.forename: Dinesh
authors.initials: D
authors.lastname: Selva
authors.forename: Michael
authors.initials: M
authors.lastname: Goggin
mesh_terms: D000772:Anesthesia, Local / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000009:adverse effects*; D007249:Inflammation / Q000139:chemically induced*; D008297:Male; D009916:Orbital Diseases / Q000139:chemically induced*; D018918:Phacoemulsification; D011183:Postoperative Complications / Q000139:chemically induced*
chemical_list: D006821:Hyaluronoglucosaminidase